Duke Clinical Research Institute & Cerner Partner to Innovate Clinical Research Registries: Built on a Cerner Product called HealtheIntent

Gynecology consultation. Doctor working on computer

Duke Clinical Research Institute (DCRI) has joined with leading electronic health record (EHR) vendor Cerner to pilot the Cerner Learning Health Network and innovate clinical research registries in the process. The pilot project and study known as the Learning Registry will use electronic health records from the Cerner Learning Health Network to evaluate the use and potential of proven therapies for chronic cardiovascular disease.

Duke Clinical Research Institute (DCRI) has joined with Cerner Corporation (CERN) in the hopes to help clinicians more easily and efficiently gain health insights and guide care. The EHR vendor aims to automate data collection from multiple sources, including the electronic health care record to rapidly offer investigators access to important information that has the potential to transform patient care.

The pilot, called the Learning Registry by the DCRI, will use the Cerner Learning Health Network to evaluate the use and potential impact of proven therapies for chronic cardiovascular disease.

The Goal: Bring together Data and Intelligence

The goal of these two organizations is to bring together data and intelligence to deliver clinicians insights on chronic cardiovascular disease, which if not properly treated can lead to heart disease and stroke and of course death in many cases.

Underlying Partnerships/Data Structures

In the Pilot, DCRI will use Cerner Technology to analyze de-identified patient data from participating health systems including:

  1. University of Missouri Health Care 
  2. Ascension Seton 
  3. Dell Medical School at the University of Texas at Austin

All to find the most effective treatment options.

After the Pilot

Once the pilot study is complete, the Cerner Learning Health Network is expected to have wide-reaching applications in life sciences, pharmaceuticals and health care at large. Why? The position that the automation and streamlining of health data for clinical research has the potential to speed innovation and life-saving insights. A fundamental underlying assumption to all of this is that more research on populations’ health offers clinicians additional tools to help them identify and treat a myriad of diseases and health concerns.

Underlying this Press Release: Products for Sale

A key factor here is a product Cerner as for sale called HealtheDataLab™ with the Cerner Learning Health Network which purports to aggregate de-identified patient data from both Cerner and non-Cerner EHRs. Cerner promotes the tool as “ground-breaking” as it leverages the capabilities of HealtheIntent, Cerner’s big data and insights platform for population health management.

What is HealtheDataLab

Clinical investigators and researchers, it is touted, can use this product to take de-identified patient data, transform the data sets into research-ready formats and build complex models and algorithms to offer providers more information to make better more decisions. Cerner promotes the underlying predictive modeling capabilities supporting early identification of individuals who may be at risk for costly episodes of care, supporting research team to identify the most at-risk individuals and pinpointing the most effective and cost-efficient treatment options.

Investigator Comment

Dr. Ann Marie Navar, principal investigator, and cardiovascular prevention researchers note “Current models for clinical research and registries that rely on mostly manual chart abstraction are too expensive, too slow and too small to continue. We have to figure out better ways to leverage existing electronic resources to transform how we do clinical research.”  Dr. Navar continued “The EHR is an obvious starting point and HealtheIntent has the right ingredients. It incorporates data from multiple EHRs, can link to national mortality and claims databases and helps us to harness the power of information security of cloud computing.”

Pilot Study Results

In a good move, the DCRI plans to publish the pilot results in a study sponsored by Janssen Pharmaceuticals, Inc (J&J), with several products used to treat and prevent cardiovascular disease.